Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Lake

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Molecular Cell Biology Research Communications : MCBRC|February 23, 2000
Structure of the Mesothelin/MPF gene and characterization of its promoterD Urwin, R A Lake
Methods in Molecular Biology (Clifton, N.J.)|March 19, 2011
Transfection of the ChloramphenicolAcetyltransferase Gene into Eukaryotic Cells Using Diethyl-Aminoethyl (DEAE)-DextranR A Lake, M J Owen
Clinical and Experimental Immunology|July 1, 1988
A monoclonal DNA-binding autoantibody causes a deterioration in renal function in MRL mice with lupus diseaseR A Lake, N A Staines
Immunology and Cell Biology|January 29, 2000
Partial T cell activation with an altered superantigenic ligandJ D Hayball, R A Lake
Immunology and Cell Biology|December 15, 2000
Altered superantigenic ligands demonstrate the quantitative nature of T-cell activationJ D Hayball, R A Lake
Lung Cancer (Amsterdam, Netherlands)|April 28, 2001
Localised spontaneous regression in mesothelioma -- possible immunological mechanismB W Robinson, C Robinson, R A Lake
Fertility and Sterility|January 1, 1982
Mixed erythrocyte-spermatozoa antiglobulin reaction (MAR test) for IgA antisperm antibodies in subfertile malesW F Hendry, J Stedronska, R A Lake
The EMBO Journal|October 1, 1990
A 3' transcriptional enhancer regulates tissue-specific expression of the human CD2 geneR A Lake, D Wotton, M J Owen
Lung Cancer (Amsterdam, Netherlands)|September 11, 1998
Sera from patients with malignant mesothelioma can contain autoantibodiesC Robinson, B W Robinson, R A Lake
Tissue Antigens|May 9, 2009
Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesotheliomaM J McCoy, A K Nowak, R A Lake
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Molecular Cell Biology Research Communications : MCBRC|February 23, 2000
Structure of the Mesothelin/MPF gene and characterization of its promoterD Urwin, R A Lake
Methods in Molecular Biology (Clifton, N.J.)|March 19, 2011
Transfection of the ChloramphenicolAcetyltransferase Gene into Eukaryotic Cells Using Diethyl-Aminoethyl (DEAE)-DextranR A Lake, M J Owen
Clinical and Experimental Immunology|July 1, 1988
A monoclonal DNA-binding autoantibody causes a deterioration in renal function in MRL mice with lupus diseaseR A Lake, N A Staines
Immunology and Cell Biology|January 29, 2000
Partial T cell activation with an altered superantigenic ligandJ D Hayball, R A Lake
Immunology and Cell Biology|December 15, 2000
Altered superantigenic ligands demonstrate the quantitative nature of T-cell activationJ D Hayball, R A Lake
Lung Cancer (Amsterdam, Netherlands)|April 28, 2001
Localised spontaneous regression in mesothelioma -- possible immunological mechanismB W Robinson, C Robinson, R A Lake
Fertility and Sterility|January 1, 1982
Mixed erythrocyte-spermatozoa antiglobulin reaction (MAR test) for IgA antisperm antibodies in subfertile malesW F Hendry, J Stedronska, R A Lake
The EMBO Journal|October 1, 1990
A 3' transcriptional enhancer regulates tissue-specific expression of the human CD2 geneR A Lake, D Wotton, M J Owen
Lung Cancer (Amsterdam, Netherlands)|September 11, 1998
Sera from patients with malignant mesothelioma can contain autoantibodiesC Robinson, B W Robinson, R A Lake
Tissue Antigens|May 9, 2009
Chemoimmunotherapy: an emerging strategy for the treatment of malignant mesotheliomaM J McCoy, A K Nowak, R A Lake
Pageof 5